400
Participants
Start Date
April 26, 2019
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
AVR with or without CABG
Surgical aortic valve implantation with INSPIRIS RESILIA Aortic Valve™
Heart Center Hietzing, Vienna
Medical University Vienna, Vienna
University Clinics St. Pölten, Sankt Pölten
Hopital de la Timone, Marseille
Centro Cardiologico Monzino, Milan
University Hospital Virgen de la Arrixaca, Murcia
Centre Hospitalier Universitaire (CHU) de Rennes, Rennes
L'institut du thorax - CHU (Centre Hospitalier Universitaire de Nantes), Nantes
University Hospital Careggi, Florence
UNIVERSITÄTSKLINIKUM FREIBURG, Universitäts-Herzzentrum Herz- und Gefäßchirurgie, Freiburg im Breisgau
AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno
KU Leuven, Leuven
CHRU - Hospital Trousseau, Tours
Heart Center Leipzig, Leipzig
European Hospital Rome, Roma
Institut de Cardiologie de Montréal, Université de Montréal, Montreal
Laval University, Québec
Erasmus Medisch Centrum, Rotterdam
NHS Lothian, Edinburgh
Glenfield Hospital, Glenfield
King's College Hospital NHS Foundation Trust, London
Collaborators (1)
Edwards Lifesciences
INDUSTRY
Institut für Pharmakologie und Präventive Medizin
NETWORK